204 related articles for article (PubMed ID: 36533576)
1. Role of follistatin-like protein 1 in liver diseases.
Gu C; Xue H; Yang X; Nie Y; Qian X
Exp Biol Med (Maywood); 2023 Feb; 248(3):193-200. PubMed ID: 36533576
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of Fstl1 attenuates hepatic stellate cell activation through the TGF‑β1/Smad3 signaling pathway.
Shang H; Liu X; Guo H
Mol Med Rep; 2017 Nov; 16(5):7119-7123. PubMed ID: 28901425
[TBL] [Abstract][Full Text] [Related]
3. Targeting Follistatin like 1 ameliorates liver fibrosis induced by carbon tetrachloride through TGF-β1-miR29a in mice.
Xu XY; Du Y; Liu X; Ren Y; Dong Y; Xu HY; Shi JS; Jiang D; Xu X; Li L; Xu ZH; Geng Y
Cell Commun Signal; 2020 Sep; 18(1):151. PubMed ID: 32933544
[TBL] [Abstract][Full Text] [Related]
4. FSTL1 Secreted by Activated Fibroblasts Promotes Hepatocellular Carcinoma Metastasis and Stemness.
Loh JJ; Li TW; Zhou L; Wong TL; Liu X; Ma VWS; Lo CM; Man K; Lee TK; Ning W; Tong M; Ma S
Cancer Res; 2021 Nov; 81(22):5692-5705. PubMed ID: 34551961
[TBL] [Abstract][Full Text] [Related]
5. Follistatin-like 1 in vertebrate development.
Sylva M; Moorman AF; van den Hoff MJ
Birth Defects Res C Embryo Today; 2013 Mar; 99(1):61-9. PubMed ID: 23723173
[TBL] [Abstract][Full Text] [Related]
6. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
[TBL] [Abstract][Full Text] [Related]
7. FSTL1 contributes to tumor progression via attenuating apoptosis in a AKT/GSK-3β - dependent manner in hepatocellular carcinoma.
Yang W; Wu Y; Wang C; Liu Z; Xu M; Zheng X
Cancer Biomark; 2017 Jul; 20(1):75-85. PubMed ID: 28655132
[TBL] [Abstract][Full Text] [Related]
8. Metabolic crosstalk between skeletal muscle cells and liver through IRF4-FSTL1 in nonalcoholic steatohepatitis.
Guo S; Feng Y; Zhu X; Zhang X; Wang H; Wang R; Zhang Q; Li Y; Ren Y; Gao X; Bian H; Liu T; Gao H; Kong X
Nat Commun; 2023 Sep; 14(1):6047. PubMed ID: 37770480
[TBL] [Abstract][Full Text] [Related]
9. Follistatin-like 1 (FSTL1) interacts with Wnt ligands and Frizzled receptors to enhance Wnt/β-catenin signaling in obstructed kidneys in vivo.
Zhang Y; Wang Y; Zheng G; Liu Y; Li J; Huang H; Xu C; Zeng Y; Zhang X; Qin J; Dai C; Hambrock HO; Hartmann U; Feng B; Mak KK; Liu Y; Lan HY; Huang Y; Zheng ZH; Xia Y
J Biol Chem; 2022 Jul; 298(7):102010. PubMed ID: 35525270
[TBL] [Abstract][Full Text] [Related]
10. Follistatin-like protein 1 regulates chondrocyte proliferation and chondrogenic differentiation of mesenchymal stem cells.
Chaly Y; Blair HC; Smith SM; Bushnell DS; Marinov AD; Campfield BT; Hirsch R
Ann Rheum Dis; 2015 Jul; 74(7):1467-73. PubMed ID: 24641944
[TBL] [Abstract][Full Text] [Related]
11. Follistatin-like 1: A dual regulator that promotes cardiomyocyte proliferation and fibrosis.
Hu S; Liu H; Hu Z; Li L; Yang Y
J Cell Physiol; 2020 Sep; 235(9):5893-5902. PubMed ID: 32017077
[TBL] [Abstract][Full Text] [Related]
12. Follistatin-like 1 in development and human diseases.
Mattiotti A; Prakash S; Barnett P; van den Hoff MJB
Cell Mol Life Sci; 2018 Jul; 75(13):2339-2354. PubMed ID: 29594389
[TBL] [Abstract][Full Text] [Related]
13. Follistatin-like Protein 1 Inhibits Lung Cancer Metastasis by Preventing Proteolytic Activation of Osteopontin.
Chiou J; Chang YC; Tsai HF; Lin YF; Huang MS; Yang CJ; Hsiao M
Cancer Res; 2019 Dec; 79(24):6113-6125. PubMed ID: 31653686
[TBL] [Abstract][Full Text] [Related]
14. Follistatin-like 1 attenuates differentiation and survival of erythroid cells through Smad2/3 signaling.
Wu J; Dong Y; Teng X; Cheng M; Shen Z; Chen W
Biochem Biophys Res Commun; 2015 Oct; 466(4):711-6. PubMed ID: 26365350
[TBL] [Abstract][Full Text] [Related]
15. Endogenous Follistatin-like 1 guarantees the immunomodulatory properties of mesenchymal stem cells during liver fibrotic therapy.
Zheng X; Zhou X; Ma G; Yu J; Zhang M; Yang C; Hu Y; Ma S; Han Z; Ning W; Jin B; Zhou X; Wang J; Han Y
Stem Cell Res Ther; 2022 Aug; 13(1):403. PubMed ID: 35932064
[TBL] [Abstract][Full Text] [Related]
16. Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development.
Geng Y; Dong Y; Yu M; Zhang L; Yan X; Sun J; Qiao L; Geng H; Nakajima M; Furuichi T; Ikegawa S; Gao X; Chen YG; Jiang D; Ning W
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7058-63. PubMed ID: 21482757
[TBL] [Abstract][Full Text] [Related]
17. Follistatin-like 1 in Cardiovascular Disease and Inflammation.
Peters MMC; Meijs TA; Gathier W; Doevendans PAM; Sluijter JPG; Chamuleau SAJ; Neef K
Mini Rev Med Chem; 2019; 19(16):1379-1389. PubMed ID: 30864520
[TBL] [Abstract][Full Text] [Related]
18. Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma.
Liu Y; Tan X; Liu W; Chen X; Hou X; Shen D; Ding Y; Yin J; Wang L; Zhang H; Yu Y; Hou J; Thompson TC; Cao G
Chin J Cancer; 2018 Jan; 37(1):2. PubMed ID: 29357946
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of follistatin-like 1 mediates tumor immune evasion in nasopharyngeal carcinoma.
Zhou X; Xiao X; Huang T; Du C; Wang S; Mo Y; Ma N; Murata M; Li B; Wen W; Huang G; Zeng X; Zhang Z
Oncotarget; 2016 Mar; 7(13):16433-44. PubMed ID: 26918942
[TBL] [Abstract][Full Text] [Related]
20. DIP2 disco-interacting protein 2 homolog A (Drosophila) is a candidate receptor for follistatin-related protein/follistatin-like 1--analysis of their binding with TGF-β superfamily proteins.
Tanaka M; Murakami K; Ozaki S; Imura Y; Tong XP; Watanabe T; Sawaki T; Kawanami T; Kawabata D; Fujii T; Usui T; Masaki Y; Fukushima T; Jin ZX; Umehara H; Mimori T
FEBS J; 2010 Oct; 277(20):4278-89. PubMed ID: 20860622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
